Center for Scientific Review; Notice of Closed Meetings, 50435-50436 [2017-23637]
Download as PDF
<![CDATA[
Federal Register / Vol. 82, No. 209 / Tuesday, October 31, 2017 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
National Institutes of Health
National Advisory Committee on Rural
Health and Human Services
Office of the Director, National
Institutes of Health; Notice of Meeting
asabaliauskas on DSKBBXCHB2PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
AGENCY: Health Resources and Service
amended, notice is hereby given of a
Administration (HRSA), Department of
meeting of the Office of AIDS Research
Health and Human Services (HHS).
Advisory Council.
The meeting will be open to the
ACTION: Notice of charter renewal.
public as indicated below, with
attendance limited to space available.
SUMMARY: HHS is hereby giving notice
Individuals who plan to attend and
that the charter for the National
need special assistance, such as sign
Advisory Committee on Rural Health
language interpretation or other
and Human Services (NACRHHS) has
reasonable accommodations, should
been renewed. The effective date of the
notify the Contact Person listed below
renewed charter is October 31, 2017.
in advance of the meeting.
The meeting will be closed to the
FOR FURTHER INFORMATION CONTACT: Paul
public in accordance with the
Moore, Designate Federal Official,
provisions set forth in section
NACRHHS, HRSA, 5600 Fishers Lane,
552b(c)(9)(B), Title 5 U.S.C., as
Room 17W41C, Rockville, Maryland
amended, for the review of
20857, telephone (301) 443–0835, fax
recommendations for the HHS
(301) 443–2803 or by email at pmoore2@ Treatment and Prevention Guidelines
hrsa.gov.
for medical care of people living with
HIV in the United States.
SUPPLEMENTARY INFORMATION:
Recommendations made from the
NACRHHS provides advice to the
working group to the OARAC will
Secretary concerning the provision and
include drug names, treatment
financing of health care and human
regimens, and prevention modalities to
services in rural areas. The current
be used for the clinical care of PLWHA.
Committee was established under
The Council may revise the draft
Section 222 of the Public Health Service
guidelines and change the content or
Act, as amended, 42 U.S.C. 217a. In
scope of treatment and prevention for
accordance with Public Law 92–463, it
HIV/AIDS as recommended in the final
was chartered on October 30, 1987, has
guidelines. Premature disclosure of draft
been renewed at appropriate intervals,
guidelines in an open meeting could
and will operate until October 31, 2019. negatively impact health and safety due
The Committee will continue to operate to the premature disclosure of
in accordance with the provisions of the information to medical providers and
Federal Advisory Committee Act
the public. Draft guidelines could be
(FACA).
misunderstood and confuse medical
providers and the public as to what is
A copy of the NACRHHS charter is
the current HHS guidelines for the
available on the NACRHHS Web site at
treatment and prevention of HIV/AIDS,
https://www.hrsa.gov/
could lead to premature changes in
advisorycommittees/rural/. A copy of
treatment regimens and prevention
the charter is also available on the
modalities that affect the health and
FACA database that is maintained by
safety of PLWHA and the public.
the Committee Management Secretariat
Name of Committee: Office of AIDS
under the General Services
Research Advisory Council.
Administration. The Web site for the
Date: November 16, 2017.
FACA database is https://
Open: 8:30 a.m. to 12:00 p.m.
www.facadatabase.gov/.
Agenda: OAR Director’s Report, updates
Amy McNulty,
Acting Director, Division of the Executive
Secretariat.
[FR Doc. 2017–23562 Filed 10–30–17; 8:45 am]
BILLING CODE 4165–15–P
VerDate Sep<11>2014
17:37 Oct 30, 2017
Jkt 244001
from the DHHS HIV Treatment and
Prevention Guidelines, OAR Task Force on
Cost Sharing, and plans for the Clinical Trials
Networks from the National Institute of
Allergy and Infectious Diseases.
Place: National Institutes of Health, Room
ID13, 5601 Fishers Lane, Bethesda, MD
20892.
Closed: 12:30 p.m. to 1:00 p.m.
Agenda: To evaluate and review
recommendations for the HHS Treatment and
Prevention Guidelines.
PO 00000
Frm 00065
Fmt 4703
Sfmt 4703
50435
Place: National Institutes of Health, Room
ID13, 5601 Fishers Lane, Bethesda, MD
20892.
Open: 1:00 p.m. to 4:30 p.m.
Agenda: Update from the National Heart,
Lung, and Blood Institute on the merger of
the MACS and WIHS, and updates on HIV/
AIDS Research Activities from the Eunice
Kennedy Shriver National Institute of Child
Health and Human Development and the
National Institute on Aging.
Place: National Institutes of Health Room
ID13, 5601 Fishers Lane, Bethesda, MD
20892.
Contact Person: Elizabeth S. Church, Ph.D.,
Executive Secretary , Office of AIDS
Research, DPCPSI, Office of the Director,
5601 Fishers Lane, Room 2E–60, Rockville,
MD 20852–9830, 240–627–3201,
elizabeth.church@nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page:
www.oar.nih.gov, where an agenda and any
additional information for the meeting will
be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.14, Intramural Research
Training Award; 93.22, Clinical Research
Loan Repayment Program for Individuals
from Disadvantaged Backgrounds; 93.232,
Loan Repayment Program for Research
Generally; 93.39, Academic Research
Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan
Repayment Program; 93.187, Undergraduate
Scholarship Program for Individuals from
Disadvantaged Backgrounds, National
Institutes of Health, HHS)
Dated: October 26, 2017.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–23641 Filed 10–30–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
E:\FR\FM\31OCN1.SGM
31OCN1
50436
Federal Register / Vol. 82, No. 209 / Tuesday, October 31, 2017 / Notices
asabaliauskas on DSKBBXCHB2PROD with NOTICES
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Language and Cognition.
Date: November 17, 2017.
Time: 11:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Samantha Smith, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3170,
Bethesda, MD 20892, 301–827–5491,
samanthasmith@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: AIDS and AIDS Related Research.
Date: November 22, 2017.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications and/or proposals.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Jose H. Guerrier, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5218,
MSC 7852, Bethesda, MD 20892, 301–435–
1137, guerriej@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR–17–
144: Limited Competition: National Primate
Research Centers (P51).
Date: November 28–30, 2017.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites by Hilton
Sacramento Riverfront, 100 Capitol Mall,
Sacramento, CA 95814.
Contact Person: Maribeth Champoux,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3170,
MSC 7848, Bethesda, MD 20892, 301–594–
3163, champoum@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Lasker
Clinical Research Scholars Program.
Date: November 28, 2017.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Abdelouahab Aitouche,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4222,
MSC 7814, Bethesda, MD 20892, 301–435–
2365, aitouchea@csr.nih.gov.
VerDate Sep<11>2014
17:37 Oct 30, 2017
Jkt 244001
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Fellowships: Cancer Immunology and
Immunotherapy.
Date: November 29, 2017.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Charles Selden, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5187,
MSC 7840, Bethesda, MD 20892, 301–451–
3388, seldens@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Interdisciplinary Molecular
Sciences and Training.
Date: November 29, 2017.
Time: 11:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Alexander Gubin, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6046B,
MSC 7892, Bethesda, MD 20892, 301–408–
9655, gubina@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Retinopathies and Viral Eye
Infections.
Date: November 29, 2017.
Time: 11:45 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Alessandra C. Rovescalli,
Ph.D., Scientific Review Officer, National
Institutes of Health, Center for Scientific
Review, 6701 Rockledge Drive, Rm 5205
MSC7846, Bethesda, MD 20892, (301) 435–
1021, rovescaa@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; APOE2 and
Alzheimer’s Disease.
Date: November 29, 2017.
Time: 1:00 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Carol Hamelink, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4192,
MSC 7850, Bethesda, MD 20892, (301) 213–
9887, hamelinc@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
PO 00000
Frm 00066
Fmt 4703
Sfmt 9990
Dated: October 25, 2017.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–23637 Filed 10–30–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; NIAID Clinical Trial
Implementation Grant (R01).
Date: November 20, 2017.
Time: 11:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 5601
Fishers Lane, Rockville, MD 20892
(Telephone Conference Call).
Contact Person: Jay R. Radke, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
Room #3G11B, National Institutes of Health,
NIAID, 5601 Fishers Lane MSC–9823,
Bethesda, MD 20892–9823, (240) 669–5046,
jay.radke@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: October 25, 2017.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–23640 Filed 10–30–17; 8:45 am]
BILLING CODE 4140–01–P
E:\FR\FM\31OCN1.SGM
31OCN1
]]>Agencies
[Federal Register Volume 82, Number 209 (Tuesday, October 31, 2017)]
[Notices]
[Pages 50435-50436]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-23637]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material,
[[Page 50436]]
and personal information concerning individuals associated with the
grant applications, the disclosure of which would constitute a clearly
unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Language and Cognition.
Date: November 17, 2017.
Time: 11:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Samantha Smith, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3170, Bethesda, MD 20892, 301-
827-5491, [email protected].
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: AIDS and AIDS Related Research.
Date: November 22, 2017.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications and/or
proposals.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Jose H. Guerrier, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5218, MSC 7852, Bethesda, MD
20892, 301-435-1137, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR-17-144: Limited Competition: National Primate Research
Centers (P51).
Date: November 28-30, 2017.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Embassy Suites by Hilton Sacramento Riverfront, 100
Capitol Mall, Sacramento, CA 95814.
Contact Person: Maribeth Champoux, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3170, MSC 7848, Bethesda, MD
20892, 301-594-3163, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Lasker Clinical Research Scholars Program.
Date: November 28, 2017.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Abdelouahab Aitouche, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4222, MSC 7814, Bethesda, MD
20892, 301-435-2365, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Fellowships: Cancer Immunology and Immunotherapy.
Date: November 29, 2017.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Charles Selden, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5187, MSC 7840, Bethesda, MD
20892, 301-451-3388, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Interdisciplinary Molecular Sciences and
Training.
Date: November 29, 2017.
Time: 11:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Alexander Gubin, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6046B, MSC 7892, Bethesda, MD
20892, 301-408-9655, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Retinopathies and Viral Eye Infections.
Date: November 29, 2017.
Time: 11:45 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Alessandra C. Rovescalli, Ph.D., Scientific
Review Officer, National Institutes of Health, Center for Scientific
Review, 6701 Rockledge Drive, Rm 5205 MSC7846, Bethesda, MD 20892,
(301) 435-1021, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; APOE2 and Alzheimer's Disease.
Date: November 29, 2017.
Time: 1:00 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Carol Hamelink, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4192, MSC 7850, Bethesda, MD
20892, (301) 213-9887, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: October 25, 2017.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-23637 Filed 10-30-17; 8:45 am]
BILLING CODE 4140-01-P
